Summary P-glycoprotein expression was demonstrated in two human intestinal adenocarcinoma cell-lines ileocaecal and T84, colonic) by immunoprecipitation of a 170-180 kDa protein with monoclonal antibody JSB-1. Both HCT-8 and T84 formed functional epithelial cell layers of high transepithelial electrical resistance (>700 Q cm2) when grown on permeable matrices. These epithelial layers demonstrated vectorial secretion (net vinblastine fluxes in the basal-to-apical direction of 0.135 and 0.452 pmol h-' cm-2 in HCT-8 and T84 cell layers, respectively, from bathing solutions containing 10 nM vinblastine). These vectorial vinblastine secretions were sensitive to inhibition by verapamil. Passive transepithelial vinblastine permeation was limited by the presence of intercellular (tight) junctions, as demonstrated by the high transepithelial electrical resistance, and verapamil increased this passive vinblastine permeation concomitant with a reduction in the electrical resistance. Cellular vinblastine loading was significantly greater from the basal side, and this was also susceptible to inhibition by basal verapamil. The demonstration of vectorial transport of vinblastine in human intestinal colonic adenocarcinoma cell layers is direct evidence in favour of the hypothesis that the function of mdrl in epithelia from the gastrointestinal tract is to promote detoxification by a process of epithelial secretion. This study also highlights that cellular vinblastine accumulation depends not only upon P-glycoprotein function, but also upon differential apparent membrane permeabilities and the presence of intercellular (tight) junctions that may restrict drug permeation and cellular accumulation to apical or basal membrane domains.
Summary P-glycoprotein expression was demonstrated in two human intestinal adenocarcinoma cell-lines ileocaecal and T84, colonic) by immunoprecipitation of a 170-180 kDa protein with monoclonal antibody JSB-1. Both HCT-8 and T84 formed functional epithelial cell layers of high transepithelial electrical resistance (>700 Q cm2) when grown on permeable matrices. These epithelial layers demonstrated vectorial secretion (net vinblastine fluxes in the basal-to-apical direction of 0.135 and 0.452 pmol h-' cm-2 in HCT-8 and T84 cell layers, respectively, from bathing solutions containing 10 nM vinblastine). These vectorial vinblastine secretions were sensitive to inhibition by verapamil. Passive transepithelial vinblastine permeation was limited by the presence of intercellular (tight) junctions, as demonstrated by the high transepithelial electrical resistance, and verapamil increased this passive vinblastine permeation concomitant with a reduction in the electrical resistance. Cellular vinblastine loading was significantly greater from the basal side, and this was also susceptible to inhibition by basal verapamil. The demonstration of vectorial transport of vinblastine in human intestinal colonic adenocarcinoma cell layers is direct evidence in favour of the hypothesis that the function of mdrl in epithelia from the gastrointestinal tract is to promote detoxification by a process of epithelial secretion. This study also highlights that cellular vinblastine accumulation depends not only upon P-glycoprotein function, but also upon differential apparent membrane permeabilities and the presence of intercellular (tight) junctions that may restrict drug permeation and cellular accumulation to apical or basal membrane domains.
The insensitivity of solid neoplasms to conventional chemotherapy has justly received considerable attention. It is increasingly apparent that certain intrinsic cellular properties of these tumour cells, often shared by the tissue of origin, contribute to such insensitivity. In a survey of 20 human colon carcinoma cell-lines (Chantret et al., 1988) the greater majority were shown to possess the basic elements of epithelial structure (cellular polarity including the formation of distinct membrane domains, and formation of tight junctions between cells) and even function (formation of a barrier by restriction of free diffusion, and fluid filled blisters resulting from transepithelial salt and water absorption). In two cases the expression of histotypic differentiation (apical brushborder, and brush-border specific hydrolases) was so extreme, as to allow the use of such tumour cells as valid in vitro models of the human intestinal epithelium.
P-glycoprotein is a 170-180 kDa membrane glycoprotein associated with the phenomenon of pleiotropic (multidrug) resistance (MDR) . Immunohistochemical techniques have demonstrated the presence of P-glycoprotein in the apical membranes of several epithelia (Sugawara et al., 1988; Cordon-Cardo et al., 1990; Thiebaut et al., 1989; Thiebaut et al., 1987) , especially in the gastrointestinal tract, e.g., jejunum, colon, liver (bile duct canaliculi), and pancreas, indicating some intrinsic function (Cordon-Cardo et al., 1990) . Retroviral transfection of a dog kidney epithelial cell-line (MDCK) with mdrl cDNA results in polarised expression of P-glycoprotein to the apical plasma membrane domain (Pastan et al., 1988) .
In many cases, tumours developing from epithelial tissues tend to possess an innate resistance to the anticancer drugs prior to any treatment regime being performed (Fojo et al., 1987; Klohs & Steinkampf, 1988; Goldstein et al., 1989) . Thus it has been hypothesised that the P-glycoprotein is involved in detoxification mechanisms, along with other enzymic systems such as glutathione-S-transferases and cytochrome P-450 (Deffie et al., 1988; Piller 1989) (Horio et al., 1989) .
The exact mechanism by which the function of the 170-180 kDa glycoprotein mediates pleiotropic drug resistance is not fully understood, but it is now broadly accepted that reduced intracellular drug accumulation resulting from increased active (ATP-dependent) drug efflux is an important factor in the mechanism of resistance (Dano, 1973; Skovsgaard, 1978a; Skovsgaard, 1978b; Inaba et al., 1979) . Vinblastine (and verapamil, see below) specifically bind to the 170-180kDa glycoprotein (Cornwell et al., 1986; Cornwell et al., 1987; Safa et al., 1987) , suggesting a functional correlation between the levels of the membrane glycoprotein in multidrug resistant cells and the level of binding of a specific chemotherapeutic agent (Saga et al., 1986) . The levels of expression of the 170-180 kDa glycoprotein correlate with the degree of drug resistance ; Van der Bliek et al., 1988; Keizer et al., 1989) . Calcium antagonists (e.g., verapamil), calmodulin inhibitors (e.g., trifluoperazine) and other agents (e.g., reserpine) inhibit the active drug efflux and restore drug sensitivity in multidrug resistant cells (Tsuruo, 1983; Kessel & Wilberding, 1984; Kessel & Wilberding, 1985; Bellamy et al., 1988; Twentyman et al., 1986) . (Madara et al., 1987; Chan et al., 1989 Dharmsathaphorn et al. (1984) and Simmons (1990) . Cells were seeded at high density (1 x 106 cells ml-', 3 ml well) into rat-tail collagen coated filtercups, Transwell 24.5 mm diam. (Costar) for or Anocell 25 mm diam. (Anotec) for T84 cells. Filtercups were then cultured in 6-well plates at 37°C, 5% CO2 for 1 week or 1 month for HCT-8 and T84, respectively, with medium replacement every 2-3 days. The formation of functional epithelial layers was monitored by the development of a significant transepithelial resistance (R,), as measured using a WPI Evometer fitted with 'chopstick' electrodes to allow transepithelial current passage and potential sensing (Simmons, 1990 [3H]-Vinblastine uptake was terminated by removal of isotope-containing medium, the plates were washed as described above, and 0.5 ml trypsin/EDTA (0.05%/0.2%) solution added. The resulting cell suspensions were collected into scintillation vials. 3H-Activities (d.p.m.) were determined by liquid scintillation counting (Beckman LS 5000CE spectrometer) using LKB 'Optiphase safe' scintillation cocktail. Appropriate corrections were made for quenching effects.
A second group of cell layers were preloaded for 4 h with 10 nM 3Hvinblastine sulphate in 1 ml serum-free medium in each well. Isotope-containing medium was then discarded and the cell layers washed, as described above. Fresh serumfree medium (1 ml) was then added to each well, either in the absence or presence of 0.2 mM verapamil, and the cells incubated for various times at 37°C. Following incubation the amount of 3Hvinblastine contained within the cell layers was determined exactly as described for the uptake measurements.
Uptake/efflux of 3Hvinblastine is expressed relative to cell contents at 4 h loading with 10 nM 3Hvinblastine; each incubation condition was performed in quadruplicate.
Measurement of bidirectional transepithelial [3H]-vinblastine sulphatefluxes
Measurements of transepithelial solute flux were made essentially as described by Simmons (1990) . Functional epithelial layers in filter cups were washed with 2 x 3 ml serum-free medium and placed into fresh 6-well plates containing 3 ml serum-free medium (basal solution), a further 3 ml serum-free medium was then pipetted into the upper chamber (apical solution) of the filter cup. Transepithelial resistance was measured following 10 min incubation of the cells at 37°C, as described above.
The medium on either the apical, or basal side of the monolayers was then removed and replaced with 3 ml serumfree medium containing 10 nM [3H]-vinblastine sulphate in the apical (a) or basal (b) solutions, in the presence or absence of 0.2 mM verapamil, followed by incubation at 37°C. The concentration of vinblastine was chosen to be considerably below the Km for vinblastine transport (Horio et al., 1991) and therefore well within the first-order part of the saturation curve, while the concentration of verapamil was chosen to completely block P-glycoprotein function. In order to measure the bidirectional fluxes of vinblastine sulphate (Jab, flux from apical to basal solutions, and Jsa, flux from basal to apical solutions), 100 gll samples of medium from each side of the monolayer were taken at regular intervals, 3H activities in these samples were then measured as described above. Each incubation was performed at least in triplicate. On completion of the experiments, the filter cups were washed by immersion in 11 PBS, the filters removed from their holders and placed into scintillation vials and 3H activities determined.
Inulin is a high molecular weight (-5,000) inert macromolecule which is normally excluded from cells, and is therefore used as a tracer of extracellular permeability pathways through the intercellular tight junctions, and an indicator of changes in the permeability of this paracellular pathway (Madara & Dharmsathaphorn, 1985) . Bidirectional ['4C]-inulin fluxes were determined exactly as for vinblastine sulphate fluxes.
Assessment of mitochondrial enzyme function: MTT assay Cells were seeded onto 96-well plates (10,000 cells/well) and the monolayers were allowed to grow over the following 48 h. The cells were washed with 100 iLl PBS before addition of verapamil (0-500 iM) or vinblastine (0-200nM). Stock solutions of verapamil were freshly prepared in dimethyl sulphoxide at a concentration of 10mgml-', followed by dilution in serum-free medium. Control wells were included in each plate (each solution contained the same concentration of DMSO). Cells were then incubated for either 1 or 5 h under cell culture conditions. On completion of the incubation, 50 gl of MTT reagent (consisting of 5 mg 3-[4,5-dimethylthiazo-2-yl]-2,5-diphenyltetrazolium bromide and 1.5 mg phenazine methosulphate per 5 ml PBS) was added to each well. The plates were then incubated for a further 20 min at 37°C. The cell monolayers were fixed by the further addition of 100 glA of buffered formalin, pH 7.0, to each well for 1 h. After overnight drying in air, the formazan product was extracted by addition of 100 pl acidified isopropanol to each well (1 ml 1 M HCI acid per 100 ml isopropanol) before absorbance at 570 nm was measured with a Dynatech MR700 ELISA plate reader (Allen et al., 1991) .
Assessment of lysosomal integrity: neutral red assay Cells were plated onto 96-well plates and incubated with verapamil as described above, following incubation the solutions were removed and the cells washed with 100 pl PBS/ well. The cells were then incubated for 3 h with 200 fsl neutral red (50 ,tg ml1' freshly prepared in serum-free medium). The monolayers were fixed by the addition of 100 il 1% formalin containing 1% CaCl2 for 2-3 min. This solution was then discarded and the plates were allowed to dry in air before the dye was extracted with a solution containing 1% acetic acid, 50% ethanol (1001l per well) over a period of 45 min with shaking. Absorbance was measured at 540 nm with an ELISA plate reader (Allen et al., 1991) .
Immunoprecipation of P-glycoprotein
Immunoprecipitates of the P-glycoprotein were prepared essentially as described by Hamada et al. (1987) . Briefly, 5 x 107 cells were detached by scraping, washed in ice cold 0.15 M NaCl, 0.02 M sodium phosphate buffer, pH 7.4, and centrifuged at 1,000g to form a cell pellet. The cell pellets were resuspended in 10 ml buffer S (50 mM Tris/HCl (pH 8), 140 mm NaCl, 5 mM NaF, 2 mM sodium vanadate, 0.2 mM PMSF, 0.25 Lg ml-' aprotinin, 4 mM EDTA, 0.5% sodium deoxycholate) and incubated on ice for 30 min. The suspensions were clarified by centrifugation at 10,000g for 20 min. An aliquot, 4 ml, of this cell extract was then incubated with 100 ytl monoclonal antibody to P-glycoprotein, JSB-l (Scheper et al., 1988) , with shaking for 2 h at 4°C. Protein A-Sepharose CL-4B, 200 pl, was then added (25% v/v in buffer S) and incubated for a further 30 min at 4°C with shaking. A pellet was formed by centrifugation (400 g for 2 min), and this pellet was washed five times with 2 ml ice cold buffer S before 150 p1 sample buffer (Laemmli, 1970) was added and the precipitates analysed by SDS-polyacrylamide gel electrophoresis using 5-15% linear gradient gels (Laemmli, 1970) . Gels were fixed and stained using a method as described by Thompson (1987) . 746.5 ± 47.9 Q-cm' (n = 70) after 7 days in culture. T84 cells reached a transepithelial electrical resistance of 1028.9 + 36.1 Q.cm2 (n = 25) after 28-35 days of growth. These values are characteristic of 'tight' epithelia such as the colon. HCT-8 and T84 cells display a small potential differences (Vt), basal electropositive, of 1.0 (HCT-8) or 0.4 mV (T84) when grown under these conditions (Chan et al., 1989) indicating the development of functional ion (Na+, Cl-) transepithelial transport.
Transepithelial vinblastine flux Using these functional HCT-8 and T84 epithelial layers, time-dependent movement of vinblastine sulphate was measurable, both in the apical-to-basal and basal-to-apical directions (Figure 2) . The basal-to-apical flux (Jb.a) was 0.234±0.007 (n=6) and 0.547±0.012 (n= 12) pmolh'-cm-2, and this exceeded the apical-to-basal flux (Ja.b) of 0.099 ± 0.008 (n = 7) and 0.095 ± 0.017 (n = 4) pmol h-' cm'2, in the HCT-8 and T84 epithelial layers, respectively. A net flux (net = J Ja-b) was, therefore, observed in the basal-to-apical direction for both cell lines. The magnitude of the directional net flux being 0.135 and 0.452 pmol h-' cm-I for HCT-8 and T84, respectively, which is 1.4-or 5.75-fold greater than the unidirectional flux in the apical-to-basal direction for these cell layers. The net flux cannot be accounted for by the small electrical potential differences maintained by the epithelial layers in the experimental conditions used.
Transepithelial electrical resistance was not compromised over the time course of the experiments. A slight increase in R, was observed in both cell lines as they became equilibrated to the fresh medium; from 746.5 ± 47.9 (n = 70) to 839.3 + 'tightness' of the epithelium (i.e. the extent of the non-cellular (paracellular or junctional) pathway for solute permeation). For T84 and HCT-8 epithelia it is clear that the unidirectional apparent permeability for apical-to-basal flux (Ja.b/C) iS inversely related to Rt. This relationship is entirely consistent with a parallel permeation pathway model for vinblastine sulphate, in which a cellular (hydrophobic) rate at limiting resistance values (<600k -cm2) is present together with a paracellular (hydrophilic) rate (see Figure 5 ). The decrease in electrical resistance seen with verapamil in T84 epithelial layers is thus correlated with increased 'leakage' of vinblastine sulphate via a paracellular route.
46.1 Q cm2 (n = 42), and from 1028.0 ± 36.1 (n = 25) to 1241 ± 52.6 Q cm2 (n = 12) in the HCT-8 and T84 cell layers, respectively. Thus, vinblastine sulphate, at the concentrations used, did not materially alter the barrier formed by the HCT-8 and T84 cells. The integrity of this barrier in HCT-8 cells was also evaluated using ['4C]-inulin flux, in parallel with the vinblastine sulphate measurements. After 200 min using a concentration of 1 gM ['4C]-inulin, the apparent permeability (J/C; i.e., inulin flux per cm2 . initial concentration of inulin) was 2.74 x 10-4 (Ja.b) and 1.82 x 10-4 (Jb.a) cm h-'; that is an order of magnitude lower than that seen for vinblastine flux (see below and Figure 3) .
Verapamil, at a concentration of 0.2 mM, reduced the net transport of vinblastine sulphate across the epithelial cell layers, primarily by an approximate 50% reduction in basalto-apical flux in both cell lines (Figure 2 ). This effect was similar with verapamil added to either the apical or basolateral solutions; e.g. in HCT-8 cell layers, Jab was 0.102 + 0.006 (n = 8) and 0.126 ± 0.001 (n = 6) with basal and apical verapamil, respectively, giving an average flux of 0.110 + 0.004 (n = 14) pmol h' cm2 illustrated in Figure 2a .
In the presence of verapamil, 0.2 mM, for 300 min the transepithelial electrical resistance fell from control values of 839.3 ± 46.1Qcm2 (n = 42) to 656.8 ± 68.2Qcm2 (n = 9) in the HCT-8 cell layers, a decrease of 21.7%. In the T84 cell layers, a 73.9% decrease in R, was observed, from 1241.1 + 52.6 (n = 12) to 323.5 ± 62.6 Q cm2 (n = 6). The verapamildependent decrease in electrical resistance correlates with the extent of drug leak across the T84 epithelial layers, reducing the apparent inhibitory effect of verapamil on the basal-toapical flux (Figure 2b) . Figure 3 illustrates a scatter diagram of the apparent permeability of vinblastine sulphate (from individual data for Ja-b) in T84 and HCT-8 epithelial layers plotted against the transepithelial electrical resistance (Rt). Rt is a measure of the Cell-associated vinblastine content The levels of cell-associated vinblastine sulphate after 200 min incubation was dependent on several factors, including the side of the cell layer exposed to the drug. A significantly increased vinblastine level was measured in those cell layers exposed to the drug from the basolateral surface compared to the apical surface (Table I ). In the HCT-8 cells cellular vinblastine content was 1.8-fold greater when loading was from the basal side. In the T84 cells, the cellular vinblastine content was approximately 5-fold greater with basal loading. These differences cannot be explained by tracer binding to the filter matrix on which the cells are grown.
In the HCT-8 cell layers no difference was seen in cellular vinblastine content as a consequence of apical or basal exposure until the transepithelial electrical resistance of the layers exceeded -300 Q cm2, For example, when HUT-8 cell layers with an average resistance of 298.5 ± 32.1 Q cm2 (n = 4) were loaded with vinblastine sulphate, as above, the cell associated drug was found to be either 0.111 pmol cm2 (n = 2) (drug presented apically) or 0.107 pmol cm2 (n = 2) (drug presented basally); i.e. no difference. This implies that access of vinblastine sulphate to either epithelial surface occurs, whether label is present in apical or basal solutions in low resistance (leaky or incomplete) layers. (Table I) . In contrast, a 29% increase in cell vinblastine content was observed when verapamil was presented on the apical surface, with [3H]-vinblastine on the basolateral surface (Table I) . No significant difference in the lower levels of cellular vinblastine loading with apical presentation was evident as a result of verapamil treatment (Table I) .
Assessment of acute verapamil and vinblastine toxicity A high concentration of verapamil was employed in these experiments to inhibit P-glycoprotein function. In preliminary experiments in verapamil, 200 jLM, was required to reduce the basal-to-apical flux of vinblastine to that of the passive apical-to-basal flux rate, i.e. 100% inhibition (e.g., see Figure 2a ). HCT-8 cells showed no reduction in viability upon incubation for 5 h, the maximum duration of the flux experiments, with concentrations of verapamil upto and including 200 gAM (Figure 4a) . However, at higher concentrations, above 300 gM, the reduction of formazan dye was increased, consistent with an increased cellular permeability to the MTT reagent, with no evidence of reduction in mitochondrial enzyme function. Acute incubation with vinblastine, 0.1-200 nM, for 5 h did not effect HCT-8 cell viability assessed by the MTT assay. Similar exposure of the cells to vinblastine followed by removal of the vinblastine, and culture for a further 48 h, is, however, associated with a reduction of formazan dye production, consistent with the well recognised cytostatic action of this Using the neutral red assay to assess toxicity (Figure 4b ), a relatively low concentration of verapamil, 20 tM, was associated with an approximate 20% reduction in lysosomal and/ or plasma membrane permeability, but this was not reduced further by increasing concentrations of verapamil.
Immunoprecipitation of P-glycoprotein Immunoprecipitation of whole cell extracts (same cell number) of HCT-8 and T84 with the monoclonal antibody JSB-1 followed by SDS-PAGE analysis yielded the protein band patterns seen in Figure 5 . A single diffuse band was detected by silver staining, with a Mr value of 170-180 kDa consistent with expression of P-glycoprotein in both cell types. It is also clear from the gel that a greater amount of the protein is present within T84 cells when compared to HCT-8 cells. No high M, bands were visible on gels if either the JSB-1 antibody or the cell extracts were omitted. [Verapamill (,uM) ., (Figure 1) . Thirdly, net secretory flux is itself inhibited by verapamil (Figure 2) . Finally, the increased amount of Pglycoprotein expression detected in T84 cells ( Figure 5 ) correlates with the greater vinblastine flux asymmetry in this cell-line (Figure 2) . In a study of vectorial transport of vinblastine by dog kidney cells transfected with a retroviral vector containing mdrl, increased vectorial transfer was seen upon transfection (Horio et al., 1989) . The present data are, therefore, the first direct demonstration in favour of the hypothesis that the function of mdrl in epithelia from the gastrointestinal tract is to promote detoxification by a process of epithelial secretion.
Determination of expression of P-glycoprotein by immunoprecipitation relies on the use of monoclonal antibody JSB-1 which recognises a highly conserved epitope, most probably on a cytoplasmic domain of the protein (Scheper et al., 1988) . Monoclonal antibody C219 also recognises a cytoplasmic epitope of the protein (Kartner et al., 1985) . In our hands antibody C219 weakly immunoprecipitates a band of circa 170 kDa, but in addition a number of other major bands are present in the immunoprecipitate suggesting that the epitope recognised by C219 is not unique to P-glycoprotein, even in non-muscle cells (Thiebaut et al., 1989) . Previous studies on HCT-8 cells have shown that although verapamil increases adriamycin accumulation and cytotoxicity, surface labelling failed to detect a glycoprotein of appropriate molecular size due to the insensitivity of the technique (Klohs & Steinkampf, 1988 (Beck, 1987) . The non-first order kinetic behaviour of vinblastine accumulation and efflux in HCT-8 cells (Figure 1) with final delivery to the apical membrane ( Figure 6 ). Polarisation in endocytotic trafficking mechanisms from the apical and basolateral surfaces has been demonstrated in Caco-2 colonic adenocarcinoma cells (Hughson & Hopkins, 1990 ). It has also been reported that a significant transcytosis (bulk directional transcellular transport by a population of endocytotic vesicles) of extracellular marker compounds exists in Caco-2 cells, oriented from basal to apical cell surfaces (Heyman et al., 1990 The present data lend support to the linkage between the intrinsic drug resistance of colon tumours and a detoxification mechanism present within normal cells (Klohs & Steinkampf, 1988; Horton et al., 1989) . Additionally, the demonstration of net vinblastine transport across an epithelial layer in which the basal bathing solution is progressively depleted of vinblastine suggests that an epithelial surface formed within a solid tissue mass or multicellular spheroid could generate a compartment that was relatively depleted of cytotoxic drug (Nederman & Twentyman, 1984) . Thus, cells displaying epithelial junction formation and P-glycoprotein expression could confer 'resistance' to an enclosed non-differentiated cell population. Little direct experimental data is available at present to support this contention, but we note that epithelial 'spheroids' composed of an outer differentiated cell-layer enclosing a progressively de-differentiated cell mass are considered, by some, as more realistic models of solid tumour cell systems (Nederman & Twentyman, 1984) . In colonic tumours in situ, P-glycoprotein expression was inhomogeneous in the tumour, but was enhanced at the luminal membrane face (Cordon-Cardo et al., 1990) ; in situations where a tumour mass and invasion front into underlying tissue could be defined, P-glycoprotein has been reported to be preferentially localised in cells at the invasion front (Weinstein et al., 1990) .
The reconstitution in vitro of intestinal epithelial function in monolayer culture in filter cups allows experimental access to both relevant cell surfaces and provides a convenient system to test cytotoxic regimes. Of special interest in this context are polar compounds that may be subject to significant diffusion restriction by the formation of a 'tight' epithelial barrier (Madara et al., 1987) . Thus inulin possesses an extremely low permeability in comparison to vinblastine, whose transepithelial permeability is likely to be predominantly transcellular in such highly resistive layers. It should be noted that as epithelial resistance decreases, apical-tobasal vinblastine permeability increases, suggesting that significant diffusion via a non-cellular polar route (the paracellular route) occurs (see Figure 3) . This result suggests that if significant diffusion restriction occurs by tight junction 
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formation within a solid tumour mass, enhanced drug permeation could be achieved by agents or drugs disrupting epithelial junction integrity (Figure 6 ). Of interest in this context is the marked reduction in transepithelial resistance of T84 epithelial layers upon incubation with verapamil that is coincident with enhanced apical-to-basal 'leak' flux of vinblastine.
An additional facet of the expression of an epithelial phenotype is the existence of separate apical and basolateral plasma membrane domains with a unique lipid and integral membrane protein composition . Also membrane amplification (via the presence of a brushborder or extensive interdigitations of the basolateral surface) can significantly alter the effective surface areas for drug diffusion into the cytosol. In the extensively studied MDCK dog kidney cell-line, careful morphometric data show that the basolateral surface area exceeds that of the apical membrane by 7-10-fold (von Bonsdorff et al., 1985; Lamb et al., 1981) . For epithelial colonic adenocarcinoma cells grown upon plastic the basolateral surface will be inaccessible from the apical medium due to tight-junction formation. The present data show that the cellular vinblastine content, and the effect of inhibitors, depends upon whether the cells are grown upon plastic or a permeable matrix. In epithelial layers on a permeable matrix, vinblastine content also depends upon the surface from which the drug is presented; with basolateral presentation, cellular vinblastine is higher than with apical presentation (Table I ). This implies that with a constant pump rate via P-glycoprotein, overall drug permeation via the basolateral membrane exceeds that of the apical surface due to differences in membrane area and/or lipid composition. Verapamil reduced cell-associated vinblastine when presented from the basal surface, with vinblastine also presented basally (Table I) , presumably by reducing drug influx, since inhibition of P-glycoprotein mediated efflux alone would increase cell vinblastine. Verapamil was equally effective from either epithelial surfaces in inhibition of vectorial transepithelial vinblastine transport, suggesting that verapamil access to P-glycoprotein was not limited by apical or basolateral membranes.
The present data emphasise the potential importance of the expression of epithelial characteristics in intestinal adenocarcinoma cells towards an understanding of the biology of a tumour in vivo. P-glycoprotein function within an epithelial adenocarcinomal sheet generates net solute (vinblastine) flux consistent with its tissue of origin. Cellular accumulation of vinblastine within an epithelial sheet is not solely dependent upon P-glycoprotein function, and this study highlights the importance of differential membrane and junctional permeabilities ( Figure 6 ). It is recognised that a variety of mechanisms are involved in mediating the modulation of MDR by chemosensitisers such as verapamil. In addition to inhibiting P-glycoprotein-mediated drug efflux, verapamil has also been described as inhibiting the ATP-dependent efflux of other xenobiotics such as bis-carboxyethyl-carboxyfluorescein (Allen et al., 1990 ) and methotrexate (Sirotnak & O'Leary, 1991) . In the present study our primary purpose has been to define P-glycoprotein-mediated flux in epithelial layers. The use of high concentrations of verapamil was necessitated by the requirement to inhibit maximally and rapidly P-glycoprotein pump activity. Non-specific effects of verapamil on epithelial function (e.g., intercellular junctional permeability) and cellular membrane permeability were noted (Figure 4b and 6), but these were not associated with acute toxicity assessed in the MTT assay. However, it is recognised that the chemosensitising action of verapamil is likely to be multifactorial, and may include perturbation of plasma membranes or lysosomal function, alterations in calcium homoeostasis, inhibition of other intracellular regulatory mechanisms (Ford & Hait, 1990) , as well as interaction with P-glycoprotein.
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